These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6107587)

  • 1. Intravenous and oral disopyramide after myocardial infarction.
    Nicholls DP; Haybyrne T; Barnes PC
    Lancet; 1980 Nov; 2(8201):936-8. PubMed ID: 6107587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
    Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
    Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH
    Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral disopyramide in the prevention of ventricular arrhythmias following myocardial infarction in patients managed on the coronary care unit and open ward.
    Kidner PH; Carmichael DJ
    East Afr Med J; 1978 Aug; 55(8):403-6. PubMed ID: 699858
    [No Abstract]   [Full Text] [Related]  

  • 5. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
    Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
    Sbarbaro JA; Rawling DA; Fozzard HA
    Am J Cardiol; 1979 Sep; 44(3):513-20. PubMed ID: 474432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral disopyramide on mortality and extension of infarction in cases of acute myocardial infarction admitted to open wards.
    Sharma BD; Chug S; Mathur KP
    J Assoc Physicians India; 1983 Mar; 31(3):149-51. PubMed ID: 6352667
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    Pouleur H; Chaudron JM; Reyns P
    Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmia prevention in early myocardial infarction.
    Ward JW
    Lancet; 1977 May; 1(8019):1006. PubMed ID: 67440
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
    Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.
    Wilcox RG; Rowley JM; Hampton JR; Mitchell JR; Roland JM; Banks DC
    Lancet; 1980 Oct; 2(8198):765-9. PubMed ID: 6107452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.
    Kumana CR; Rambihar VS; Willis K; Gupta RN; Tanser PH; Cairns JA; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):529-37. PubMed ID: 6753888
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.
    Ward JW; Kinghorn GR
    J Int Med Res; 1976; 4(1 Suppl):49-53. PubMed ID: 1026529
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoprophylaxis of arrhythmias with oral disopyramide in acute myocardial infarction.
    Nigam P; Khan S; Singh R; Kapoor KK; Kumar A; Gupta AK
    J Assoc Physicians India; 1983 Dec; 31(12):759-62. PubMed ID: 6370949
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic disopysramide: its clinical effects related to plasma concentration in myocardial infarction.
    Hillson RM; Boyd E; Cunningham J
    J Int Med Res; 1980; 8(5):314-20. PubMed ID: 6998791
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate.
    Wilcox RG
    Acta Med Scand Suppl; 1981; 651():193-202. PubMed ID: 6119875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disopyramide: serum level and arrhythmia conversion.
    Niarchos AP
    Am Heart J; 1976 Jul; 92(1):57-64. PubMed ID: 785988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.
    Arif M; Laidlaw JC; Oshrain C; Willis PW; Nissen CH; McDermott DJ; Smith WS; Karim A; Wilson RR
    Angiology; 1983 Jun; 34(6):393-400. PubMed ID: 6408949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-dysrhythmic treatment in acute myocardial infarction.
    Lancet; 1979 Jan; 1(8109):193-4. PubMed ID: 84210
    [No Abstract]   [Full Text] [Related]  

  • 20. Disopyramide kinetics in patients with acute myocardial infarction.
    Ilett KF; Madsen BW; Woods JD
    Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.